Biotech Next Gen 2021 has ended
Back To Schedule
Tuesday, June 22 • 9:30am - 10:30am
What's next in gene therapy

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
A first wave of gene therapies has made it to market, but it’s just a prelude to the tidal surge to come. From new viral vectors to newly refined manufacturing to entirely new targets—including infectious diseases—biotech companies are advancing first-time approaches in an already cutting-edge field. We’ll talk to some of the next-wave pioneers about how the new work will improve on the groundbreaking advances we’ve already seen.

avatar for Arlene Weintraub

Arlene Weintraub

Editor, Fierce Biotech
Arlene Weintraub has over 15 years of experience writing about health care, pharmaceuticals and biotechnology. Her freelance pieces have been published in the New York Times, US News & World Report, Technology Review, Scientific American, USA Today, Entrepreneur.com, FierceMarkets... Read More →

avatar for Bobby Gaspar, M.D., Ph.D.

Bobby Gaspar, M.D., Ph.D.

CEO and Co-Founder, Orchard Therapeutics
Dr. Gaspar is a world-renowned scientist and physician and accomplished strategic and organizational leader with more than 25 years of experience in medicine and biotechnology. As one of Orchard’s principal scientific co-founders, Dr. Gaspar serves as chief executive officer of... Read More →
avatar for R. Nolan Townsend

R. Nolan Townsend

CEO, LEXEO Therapeutics
R. Nolan Townsend currently serves as Chief Executive Officer with LEXEO Therapeutics. Prior to joining LEXEO, Mr. Townsend held roles as President, Pfizer Rare Disease for the North America and international regions, respectively. Additionally, he served in a variety of roles at... Read More →
avatar for Shankar Ramaswamy, M.D.

Shankar Ramaswamy, M.D.

CEO and Co-Founder, Kriya Therapeutics
Shankar Ramaswamy is the Co-Founder, Chairman and Chief Executive Officer of Kriya Therapeutics, a next generation fully integrated gene therapy company focused on engineering, manufacturing and developing gene therapies to address series medical conditions. Prior to launching Kriya... Read More →
avatar for RA Session II

RA Session II

President, CEO and Founder, Taysha Gene Therapies
RA Session II is the President, CEO and Founder of Taysha Gene Therapies. Mr. Session has nearly 20 years’ experience in the life sciences industry, primarily in business development, corporate strategy and financial roles. Previously, he served as Chief Business Officer of the... Read More →
avatar for Natasha C. Lucki, Ph.D.

Natasha C. Lucki, Ph.D.

Senior Product Manager, Biosciences Division, Thermo Fisher Scientific
Natasha C. Lucki, PhD is a Senior Product Manager in the Biosciences Division at Thermo Fisher Scientific in Carlsbad, CA. Natasha leads the Viral Delivery portfolio which includes the complete viral vector production platforms LV-MAX™ and AAV-MAX systems. She received her PhD in... Read More →
avatar for Manja Boerman, Ph.D.

Manja Boerman, Ph.D.

President, Catalent Cell & Gene Therapy, Catalent
Manja Boerman is the President of Catalent Cell & Gene Therapy with overall responsibility for strategy and leadership of the cell and gene businesses. Manja joined Catalent in December 2019. She has held several executive leadership positions at previous companies including Aesica... Read More →

Tuesday June 22, 2021 9:30am - 10:30am EDT